# CHARLWOOD, Andrew

Deputy Head, Population Health & Data Analysis

Active Open to opportunities
DOB 14/02/1993
NHS No 221 181 0
Registration GPhC 2211810
Location Norwich, NR1
Since August 2016
Qualification MPharm (Hons) 2:1
Clinical Record / CHARLWOOD, Andrew / Summary
Clinical Alert
This patient has identified £14.6M in prescribing efficiency savings across Norfolk & Waveney ICS, with £2M on target for delivery this financial year.
Active Problems
£220M prescribing budget oversight and management
Active Jul 2024 MGT001
Patient-level SQL analytics transformation
In Progress 2025 TRN001
Team data literacy programme
In Progress Jul 2024 LEA001
Current Medications

Drug | Proficiency | Frequency | Since
--- | --- | --- | ---
Data Analysis | 95% | Daily | 2016
Medicines Optimisation | 95% | Daily | 2016
Power BI | 92% | Daily | 2019
Python | 90% | Daily | 2017
Population Health Analytics | 90% | Daily | 2022
SQL | 88% | Daily | 2017
Dashboard Development | 88% | Weekly | 2019
NICE TA Implementation | 85% | Weekly | 2022
Algorithm Design | 82% | Weekly | 2022
JavaScript / TypeScript | 70% | Weekly | 2020

Last Consultation
Date 14 May 2025
Organisation NHS Norfolk & Waveney ICB
Duration May 2025 — Nov 2025
Interim Head, Population Health & Data Analysis

Led strategic delivery of population health initiatives and data-driven medicines optimisation across Norfolk & Waveney ICS, reporting to Associate Director of Pharmacy with presentation accountability to Chief Medical Officer and system-level programme boards.

- Identified £14.6M efficiency programme through comprehensive data analysis
- Built Python-based switching algorithm: 14,000 patients identified, £2.6M annual savings
- Automated incentive scheme analysis: 50% reduction in targeted prescribing within 2 months

Current Appointment
Date 01 Jul 2024
Organisation NHS Norfolk & Waveney ICB
Duration Jul 2024 — Present
Deputy Head, Population Health & Data Analysis Current

Driving data analytics strategy for medicines optimisation, developing bespoke datasets and analytical frameworks from messy, real-world GP prescribing data to identify efficiency opportunities and address health inequalities across the integrated care system.

- Managed £220M prescribing budget with sophisticated forecasting models
- Created comprehensive medicines data table with dm+d integration, morphine equivalents, Anticholinergic Burden scoring
- Led financial scenario modelling for DOAC switching programme
- Developed Python-based controlled drug monitoring system for population-scale OME tracking

Resolved Problems
£14.6M efficiency target identification and delivery
Over-target performance achieved
EFF002 · Resolved Oct 2025
Manual prescribing analysis inefficiency
Python algorithm: 14,000 pts, £2.6M/yr
EFF001 · Resolved Oct 2025
Incentive scheme manual calculation
Automated: 50% Rx reduction in 2 months
AUT002 · Resolved 2025
Population opioid exposure monitoring
CD monitoring system: OME tracking
MON001 · Resolved 2024
Blueteq form creation backlog
70% reduction, 200hrs saved
AUT001 · Resolved 2023
Asthma screening scalability
National rollout: ~300 branches, ~£1M
INN001 · Resolved 2019